Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 253
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Prescription for Health and Fitness Based on Your Genes

    Exercise has many health benefits. Yet, most people stop their exercise programs after they start them. What...

    Help us pioneer stem cell therapy for giraffe!

    Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

    Can we predict whether an athlete will sustain an ACL tear?

    Despite consistent investigation, the risk factors responsible for non-contact Anterior Cruciate Ligament (ACL...

    Backer Badge Funded